These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8917202)

  • 1. Quantitation of neuroreceptors: a need to increase imaging resolution?
    Kuikka JT
    J Nucl Med; 1996 Nov; 37(11):1911-2. PubMed ID: 8917202
    [No Abstract]   [Full Text] [Related]  

  • 2. Images in neuroscience. Neuroimaging, XII. SPECT imaging of dopamine nerve terminals.
    Seibyl JP; Marek K; Innis RB
    Am J Psychiatry; 1996 Sep; 153(9):1131. PubMed ID: 8780413
    [No Abstract]   [Full Text] [Related]  

  • 3. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA
    J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vivo SPECT imaging of D2 receptor with iodine-iodolisuride: results in supranuclear palsy.
    Chabriat H; Levasseur M; Vidailhet M; Loc'h C; Mazière B; Bourguignon MH; Bonnet AM; Zilbovicius M; Raynaud C; Agid Y
    J Nucl Med; 1992 Aug; 33(8):1481-5. PubMed ID: 1386104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopamine deficiency.
    Jeon BS; Jeong JM; Park SS; Lee MC
    Adv Neurol; 1998; 78():309-17. PubMed ID: 9750927
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55.
    Shaya EK; Scheffel U; Dannals RF; Ricaurte GA; Carroll FI; Wagner HN; Kuhar MJ; Wong DF
    Synapse; 1992 Feb; 10(2):169-72. PubMed ID: 1585258
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.
    Malison RT; Best SE; van Dyck CH; McCance EF; Wallace EA; Laruelle M; Baldwin RM; Seibyl JP; Price LH; Kosten TR; Innis RB
    Am J Psychiatry; 1998 Jun; 155(6):832-4. PubMed ID: 9619159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of iodine-123-beta-CIT dopamine receptor uptake in a phantom model.
    Leong LK; O'Connor MK; Maraganore DM
    J Nucl Med Technol; 1999 Jun; 27(2):117-22. PubMed ID: 10353108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
    J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.
    Malison RT; McDougle CJ; van Dyck CH; Scahill L; Baldwin RM; Seibyl JP; Price LH; Leckman JF; Innis RB
    Am J Psychiatry; 1995 Sep; 152(9):1359-61. PubMed ID: 7653693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.
    Naumann M; Pirker W; Reiners K; Lange KW; Becker G; Brücke T
    Mov Disord; 1998 Mar; 13(2):319-23. PubMed ID: 9539347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
    Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE
    J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
    Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
    J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.
    Seibyl JP; Marek KL; Quinlan D; Sheff K; Zoghbi S; Zea-Ponce Y; Baldwin RM; Fussell B; Smith EO; Charney DS; van Dyck C
    Ann Neurol; 1995 Oct; 38(4):589-98. PubMed ID: 7574455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human brain receptors,V. Binding and message.
    Meador-Woodruff JH; Watson SJ; Tamminga CA
    Am J Psychiatry; 1994 Jun; 151(6):804. PubMed ID: 8184989
    [No Abstract]   [Full Text] [Related]  

  • 20. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.